Contact
searchSearch
HMP Global

Clinical Pathways

Featured

BDHC Thumbnail
Breaking Down Health Care
Navigating Payer Challenges in Cell and Gene Therapy
11/07/2024
In this Breaking Down Health Care conversation, John Hennessy, MBA, and Michael Kolodziej, MD, discuss the challenges and potential solutions for integrating cell and gene therapies—particularly CAR T—into clinical practice and insurance...
In this Breaking Down Health Care conversation, John Hennessy, MBA, and Michael Kolodziej, MD, discuss the challenges and potential solutions for integrating cell and gene therapies—particularly CAR T—into clinical practice and insurance...
In this Breaking Down Health...
11/07/2024
Cancer Care Business Exchange
From Cancer Care Business Exchange
BDHC thumbnail
Breaking Down Health Care
Maximizing the Potential of Precision Medicine
10/07/2024
In this Breaking Down Health Care conversation, John Hennessy, MBA, and Michael Kolodziej, MD, talk about the economic challenges of precision medicine in health care, including the differences between Medicare and commercial health plans and...
In this Breaking Down Health Care conversation, John Hennessy, MBA, and Michael Kolodziej, MD, talk about the economic challenges of precision medicine in health care, including the differences between Medicare and commercial health plans and...
In this Breaking Down Health...
10/07/2024
Cancer Care Business Exchange
From Cancer Care Business Exchange
BDHC thumbnail
Breaking Down Health Care
Show Me the Medical Evidence
07/15/2024
In this Breaking Down Health Care conversation, John Hennessy, MBA, and Michael Kolodziej, MD, talk about the challenges of practicing medicine and keeping up with treatment developments when the evidence is constantly changing and evolving.
In this Breaking Down Health Care conversation, John Hennessy, MBA, and Michael Kolodziej, MD, talk about the challenges of practicing medicine and keeping up with treatment developments when the evidence is constantly changing and evolving.
In this Breaking Down Health...
07/15/2024
Cancer Care Business Exchange
From Cancer Care Business Exchange
JCP Flatiron Roundtable 1 Thumbnail
Videos
Oncology Care Pathways: Perspectives on Strategies and Best Practices
05/01/2024

Featuring Gordon Kuntz; Jeremy Drainville; James Hamrick, MD; Larry Shulman, MD; Bryan Loy, MD

Featuring Gordon Kuntz; Jeremy Drainv...
In this roundtable, participants discuss how to develop and implement clinical pathways at cancer centers. This includes integrating both the latest clinical evidence and payer contract requirements to develop the most efficient clinical...
In this roundtable, participants discuss how to develop and implement clinical pathways at cancer centers. This includes integrating both the latest clinical evidence and payer contract requirements to develop the most efficient clinical...
In this roundtable, participants...
05/01/2024
Journal of Clinical Pathways
From Journal of Clinical Pathways
Video thumbnail screenshot.
Videos
ONCare Alliance Merger Announcement: An Interview With Co-Founders Barbara McAneny, MD, and Sibel Blau, MD
03/11/2024

Featuring Barbara McAneny, MD, and Sibel Blau, MD

Featuring Barbara McAneny, MD, and Si...
Longtime industry leaders Barbara McAneny, MD, and Sibel Blau, MD, have joined forces to create ONCare Alliance, a strategic collaboration that aims to redefine the independent practice in community cancer care.
Longtime industry leaders Barbara McAneny, MD, and Sibel Blau, MD, have joined forces to create ONCare Alliance, a strategic collaboration that aims to redefine the independent practice in community cancer care.
Longtime industry leaders...
03/11/2024
Cancer Care Business Exchange
From Cancer Care Business Exchange
Stephen Speicher, MD
Videos
Safety and Quality Implications of Using Artificial Intelligence in Oncology
02/29/2024

Featuring Stephen V. Speicher, MD, MS

Featuring Stephen V. Speicher, MD, MS...
Stephen V. Speicher, MD, MS, previews his upcoming AMCCBS panel session titled “Deep Dive: Artificial and Business Intelligence Technology.”
Stephen V. Speicher, MD, MS, previews his upcoming AMCCBS panel session titled “Deep Dive: Artificial and Business Intelligence Technology.”
Stephen V. Speicher, MD, MS,...
02/29/2024
Journal of Clinical Pathways
From Journal of Clinical Pathways
Harlan Levine, MD
Videos
Expanding Access to Care Through Academic-Community Cancer Care Collaboration
01/23/2024
Harlan Levine, MD, highlights the benefits of the collaboration between community cancer centers and academic medical centers, including allowing for more access to patient care.
Harlan Levine, MD, highlights the benefits of the collaboration between community cancer centers and academic medical centers, including allowing for more access to patient care.
Harlan Levine, MD, highlights...
01/23/2024
Journal of Clinical Pathways
From Journal of Clinical Pathways
Ivy Altomare, MD
Videos
Reimagining Clinical Trials in the Community Setting
10/20/2023
Ivy Altomare, MD, Flatiron Health, discusses the current state of clinical research in community oncology and how technologies and new models are changing clinical research.
Ivy Altomare, MD, Flatiron Health, discusses the current state of clinical research in community oncology and how technologies and new models are changing clinical research.
Ivy Altomare, MD, Flatiron...
10/20/2023
Journal of Clinical Pathways
From Journal of Clinical Pathways
Will Shapiro, Flatiron Health
Conference Coverage
The Future of AI in Cancer Care
10/08/2023
Will Shapiro, vice president of Data Insights Engineering at Flatiron Health, shares insights into recent developments in the use of AI in cancer care and what advances are anticipated in this area.
Will Shapiro, vice president of Data Insights Engineering at Flatiron Health, shares insights into recent developments in the use of AI in cancer care and what advances are anticipated in this area.
Will Shapiro, vice president of...
10/08/2023
Journal of Clinical Pathways
From Journal of Clinical Pathways
James Hamrick, MD
Conference Coverage
AI in Cancer Care: Separating Fact from Fiction
10/06/2023
James Hamrick, MD, discusses his presentation "AI in Cancer Care: Separating Fact from Fiction" at the 2023 Clinical Pathways Congress + Cancer Care Business Exchange meeting.
James Hamrick, MD, discusses his presentation "AI in Cancer Care: Separating Fact from Fiction" at the 2023 Clinical Pathways Congress + Cancer Care Business Exchange meeting.
James Hamrick, MD, discusses his...
10/06/2023
Journal of Clinical Pathways
From Journal of Clinical Pathways
Barbara McAneny, MD
Conference Coverage
CPC & CBEx Session Preview: Updates from Washington, Healthcare Industry Consolidation, and Cancer Care at Home
10/03/2023
CPC & CBEx faculty member Barbara McAneny, MD, gives a preview of her three featured sessions from the conference, including key points on health care industry consolidation, legislative updates, and important considerations for delivering...
CPC & CBEx faculty member Barbara McAneny, MD, gives a preview of her three featured sessions from the conference, including key points on health care industry consolidation, legislative updates, and important considerations for delivering...
CPC & CBEx faculty member...
10/03/2023
Journal of Clinical Pathways
From Journal of Clinical Pathways

Journal of Clinical Pathways

Research Reports
Effectiveness of Eribulin in Metastatic Breast Cancer Patients With Poor Prognostic Indicators in the United States
06/21/2021
A retrospective real-world study demonstrates the clinical effectiveness of eribulin in subgroups of MBC patients with poor prognostic characteristics, when used in accordance with the approved US indication.
A retrospective real-world study demonstrates the clinical effectiveness of eribulin in subgroups of MBC patients with poor prognostic characteristics, when used in accordance with the approved US indication.
A retrospective real-world study...
06/21/2021
Journal of Clinical Pathways
Research Reports
US Value-Based Management of Oncology Drugs: An Explorative Study of Payer and Provider Tools to Manage the Rising Spending on Oncology Drugs
06/21/2021
Anne Runyan, BA , and colleagues point out that, despite increasing cancer costs in the United States, payers’ willingness and ability to manage oncology drugs remains limited.
Anne Runyan, BA , and colleagues point out that, despite increasing cancer costs in the United States, payers’ willingness and ability to manage oncology drugs remains limited.
Anne Runyan, BA , and colleagues...
06/21/2021
Journal of Clinical Pathways
Overactive Bladder Health Care Burden in the US Long-Term Care Setting: A Retrospective Cohort Study
Research Reports
Overactive Bladder Health Care Burden in the US Long-Term Care Setting: A Retrospective Cohort Study
05/18/2021
Richard Stefanacci, DO, and colleagues describe and evaluate the population, treatment patterns, HCRU, and costs associated with overactive bladder in the in the US long-term care setting.
Richard Stefanacci, DO, and colleagues describe and evaluate the population, treatment patterns, HCRU, and costs associated with overactive bladder in the in the US long-term care setting.
Richard Stefanacci, DO, and...
05/18/2021
Journal of Clinical Pathways
Assessing Clinician Attitudes and Beliefs Around Financial Toxicity Screening in Medical Oncology Clinic
Research Reports
Assessing Clinician Attitudes and Beliefs Around Financial Toxicity Screening in Medical Oncology Clinic
05/17/2021
Sylvia Zhang, MS, and colleagues discuss the attitudes, motivation, and experiences of clinicians regarding screening for financial toxicity in a medical oncology clinical setting, identifying potential opportunities for future clinician-led...
Sylvia Zhang, MS, and colleagues discuss the attitudes, motivation, and experiences of clinicians regarding screening for financial toxicity in a medical oncology clinical setting, identifying potential opportunities for future clinician-led...
Sylvia Zhang, MS, and colleagues...
05/17/2021
Journal of Clinical Pathways
Pediatric Sunscreen Coverage by Medicaid as a Primary Prevention Strategy to Reduce Melanoma Burden: A Cost-Effectiveness Analysis
Research Reports
Pediatric Sunscreen Coverage by Medicaid as a Primary Prevention Strategy to Reduce Melanoma Burden: A Cost-Effectiveness Analysis
04/22/2021
Abstract: Melanoma treatment costs continue to rise. Sunscreen is a photoprotective tool that may reduce the incidence of melanoma but can be cost prohibitive for lower socioeconomic populations. New York State...
Abstract: Melanoma treatment costs continue to rise. Sunscreen is a photoprotective tool that may reduce the incidence of melanoma but can be cost prohibitive for lower socioeconomic populations. New York State...
...
04/22/2021
Journal of Clinical Pathways
Patient Voices in Value-Based Cancer Care: Priorities for the Biden Administration
Perspectives
Patient Voices in Value-Based Cancer Care: Priorities for the Biden Administration
04/22/2021
Abstract: The Biden administration has an opportunity to prioritize patient perspectives in innovative value-based payment models for oncology by incorporating meaningful patient-reported measures (PRMs) and...
Abstract: The Biden administration has an opportunity to prioritize patient perspectives in innovative value-based payment models for oncology by incorporating meaningful patient-reported measures (PRMs) and...
...
04/22/2021
Journal of Clinical Pathways

Oncology Clinical Pathways Congress

Videos
Evolving Oncology Pathways, CLL Treatment Advances, and the Role of Multidisciplinary Care Teams
11/12/2024
Shaffee Bacchus, PharmD, discusses the evolution of oncology pathways, advancements in chronic lymphocytic leukemia (CLL) treatment, and the importance of multidisciplinary care teams in addressing comorbidities and enhancing patient quality...
Shaffee Bacchus, PharmD, discusses the evolution of oncology pathways, advancements in chronic lymphocytic leukemia (CLL) treatment, and the importance of multidisciplinary care teams in addressing comorbidities and enhancing patient quality...
Shaffee Bacchus, PharmD,...
11/12/2024
Journal of Clinical Pathways
Conference Coverage
Oncology Pathways Research: Challenges, Adoption, and Future Trends
11/08/2024
In an exclusive interview with the Journal of Clinical Pathways, Cindy Chen, Head of Research at HMP Market Access Insights, shares insights into the challenges, adoption, and future trends of oncology pathways research. Her discussion draws...
In an exclusive interview with the Journal of Clinical Pathways, Cindy Chen, Head of Research at HMP Market Access Insights, shares insights into the challenges, adoption, and future trends of oncology pathways research. Her discussion draws...
In an exclusive interview with...
11/08/2024
Journal of Clinical Pathways
Videos
Navigating Multidisciplinary Care: Insights on Oncology Practice Integration and Pharmaceutical Partnerships
11/04/2024
John Hennessy, Principal at Valuate Health Consultancy, highlights the importance of multidisciplinary collaboration in oncology care to improve patient outcomes.
John Hennessy, Principal at Valuate Health Consultancy, highlights the importance of multidisciplinary collaboration in oncology care to improve patient outcomes.
John Hennessy, Principal at...
11/04/2024
Journal of Clinical Pathways
Videos
Custom Pathways in Oncology: Innovations, Stakeholder Collaboration, and Value-Based Care
11/01/2024
James Hamrick, MD, MPH, Vice President of Clinical Oncology at Flatiron Health, highlights the importance of custom oncology pathways in enabling real-time updates for oncologists, fostering collaborative implementation teams, and supporting...
James Hamrick, MD, MPH, Vice President of Clinical Oncology at Flatiron Health, highlights the importance of custom oncology pathways in enabling real-time updates for oncologists, fostering collaborative implementation teams, and supporting...
James Hamrick, MD, MPH, Vice...
11/01/2024
Journal of Clinical Pathways
News
CPC + CBEx 2024: Influence and Impact of Oncology Pathways
09/25/2024
HMP Market Access Insights researchers shared their findings on the impact of pathway programs on treatment selections at the 2024 Clinical Pathways Congress + Cancer Care Business Exchange.
HMP Market Access Insights researchers shared their findings on the impact of pathway programs on treatment selections at the 2024 Clinical Pathways Congress + Cancer Care Business Exchange.
HMP Market Access Insights...
09/25/2024
Journal of Clinical Pathways
Conference Coverage
CPC + CBEx 2024: Integration of Medical Oncology and Surgical Specialties
09/19/2024
Presenters at the 2024 Clinical Pathways Congress + Cancer Care Business Exchange shared how their institutions integrate medical oncology and surgical specialties for genitourinary cancers and some of the challenges they face both clinically...
Presenters at the 2024 Clinical Pathways Congress + Cancer Care Business Exchange shared how their institutions integrate medical oncology and surgical specialties for genitourinary cancers and some of the challenges they face both clinically...
Presenters at the 2024 Clinical...
09/19/2024
Journal of Clinical Pathways
Conference Coverage
CPC + CBEx 2024: Pathways for Social Needs Assessment and Care
09/18/2024
In a session at the 2024 Clinical Pathways Congress + Cancer Care Business Exchange, experts went over the importance of social needs assessment and care in oncology and provided an example of pathways that help in providing these services to...
In a session at the 2024 Clinical Pathways Congress + Cancer Care Business Exchange, experts went over the importance of social needs assessment and care in oncology and provided an example of pathways that help in providing these services to...
In a session at the 2024...
09/18/2024
Journal of Clinical Pathways
Conference Coverage
CPC + CBEx 2024: Managing Clinical & Financial Risk in Oncology
09/13/2024
A group of oncology practice innovators and care platform disruptors spoke about managing clinical and financial risk in oncology as part of a session at the 2024 Clinical Pathways Congress + Cancer Care Business Exchange.
A group of oncology practice innovators and care platform disruptors spoke about managing clinical and financial risk in oncology as part of a session at the 2024 Clinical Pathways Congress + Cancer Care Business Exchange.
A group of oncology practice...
09/13/2024
Journal of Clinical Pathways
Conference Coverage
CPC + CBEx 2024: Strategies for Patient Navigation Services
09/12/2024
Learn about different implementation strategies for patient navigation presented at a session at the 2024 Clinical Pathways Congress + Cancer Care Business Exchange.
Learn about different implementation strategies for patient navigation presented at a session at the 2024 Clinical Pathways Congress + Cancer Care Business Exchange.
Learn about different...
09/12/2024
Journal of Clinical Pathways
Conference Coverage
CPC + CBEx 2024: CancerX Updates
09/11/2024
Learn about the latest initiatives from CancerX presented at a session at the 2024 Clinical Pathways Congress + Cancer Care Business Exchange.
Learn about the latest initiatives from CancerX presented at a session at the 2024 Clinical Pathways Congress + Cancer Care Business Exchange.
Learn about the latest...
09/11/2024
Journal of Clinical Pathways

Multimedia

BDHC Thumbnail
Breaking Down Health Care
Navigating Payer Challenges in Cell and Gene Therapy
11/07/2024
In this Breaking Down Health Care conversation, John Hennessy, MBA, and Michael Kolodziej, MD, discuss the challenges and potential solutions for integrating cell and gene therapies—particularly CAR T—into clinical practice and insurance...
In this Breaking Down Health Care conversation, John Hennessy, MBA, and Michael Kolodziej, MD, discuss the challenges and potential solutions for integrating cell and gene therapies—particularly CAR T—into clinical practice and insurance...
In this Breaking Down Health...
11/07/2024
Cancer Care Business Exchange
BDHC thumbnail
Breaking Down Health Care
Maximizing the Potential of Precision Medicine
10/07/2024
In this Breaking Down Health Care conversation, John Hennessy, MBA, and Michael Kolodziej, MD, talk about the economic challenges of precision medicine in health care, including the differences between Medicare and commercial health plans and...
In this Breaking Down Health Care conversation, John Hennessy, MBA, and Michael Kolodziej, MD, talk about the economic challenges of precision medicine in health care, including the differences between Medicare and commercial health plans and...
In this Breaking Down Health...
10/07/2024
Cancer Care Business Exchange
BDHC thumbnail
Breaking Down Health Care
The Government and Health Care: A Volatile or Necessary Mix? (Part II)
08/22/2024
In the second part of this Breaking Down Health Care conversation, John Hennessy, MBA, and Michael Kolodziej, MD, cover the US federal government’s role in health care—Medicare, Medicaid, and the Affordable Care Act. They discuss the...
In the second part of this Breaking Down Health Care conversation, John Hennessy, MBA, and Michael Kolodziej, MD, cover the US federal government’s role in health care—Medicare, Medicaid, and the Affordable Care Act. They discuss the...
In the second part of this...
08/22/2024
Cancer Care Business Exchange
BDHC thumbnail
Breaking Down Health Care
Why People Should Care About How Health Care Works (Part 1)
07/29/2024
In part one of this two-part Breaking Down Health Care conversation, John Hennessy, MBA, and Michael Kolodziej, MD, dive into the topic of big data: what it is, how it came about, and why we’re still struggling to leverage it.
In part one of this two-part Breaking Down Health Care conversation, John Hennessy, MBA, and Michael Kolodziej, MD, dive into the topic of big data: what it is, how it came about, and why we’re still struggling to leverage it.
In part one of this two-part...
07/29/2024
Cancer Care Business Exchange
BDHC thumbnail
Breaking Down Health Care
Show Me the Medical Evidence
07/15/2024
In this Breaking Down Health Care conversation, John Hennessy, MBA, and Michael Kolodziej, MD, talk about the challenges of practicing medicine and keeping up with treatment developments when the evidence is constantly changing and evolving.
In this Breaking Down Health Care conversation, John Hennessy, MBA, and Michael Kolodziej, MD, talk about the challenges of practicing medicine and keeping up with treatment developments when the evidence is constantly changing and evolving.
In this Breaking Down Health...
07/15/2024
Cancer Care Business Exchange
BDHC thumbnail
Breaking Down Health Care
What Does Quality Mean in Health Care?
07/01/2024
In this Breaking Down Health Care conversation, John Hennessy, MBA, and Michael Kolodziej, MD, examine how to measure quality in health care and the current challenges with the existing methods.
In this Breaking Down Health Care conversation, John Hennessy, MBA, and Michael Kolodziej, MD, examine how to measure quality in health care and the current challenges with the existing methods.
In this Breaking Down Health...
07/01/2024
Cancer Care Business Exchange
BDHC thumbnail
Breaking Down Health Care
The Balance Between Drug Safety and Availability
06/17/2024
In this Breaking Down Health Care conversation, John Hennessy, MBA, and Michael Kolodziej, MD, discuss the process of drug approvals and the role of the US Food and Drug Administration, including how and why the process takes so much time—and...
In this Breaking Down Health Care conversation, John Hennessy, MBA, and Michael Kolodziej, MD, discuss the process of drug approvals and the role of the US Food and Drug Administration, including how and why the process takes so much time—and...
In this Breaking Down Health...
06/17/2024
Cancer Care Business Exchange
BDHC thumbnail
Breaking Down Health Care
Medicare for All: Careful What You Wish for
06/03/2024
In this Breaking Down Health Care conversation, John Hennessy, MBA, and Michael Kolodziej, MD, dive into the topic of Medicare for All and universal health care: why these terms are not interchangeable, and if they could actually solve the...
In this Breaking Down Health Care conversation, John Hennessy, MBA, and Michael Kolodziej, MD, dive into the topic of Medicare for All and universal health care: why these terms are not interchangeable, and if they could actually solve the...
In this Breaking Down Health...
06/03/2024
Cancer Care Business Exchange
BDHC thumbnail
Breaking Down Health Care
The Bear: Why Does Health Care Cost So Much? (Part 2)
05/20/2024
In part two of this two-part Breaking Down Health Care conversation, John Hennessy, MBA, and Michael Kolodziej, MD, dig into the other main stakeholders in health care costs: pharmaceutical manufacturers and providers. They discuss how these...
In part two of this two-part Breaking Down Health Care conversation, John Hennessy, MBA, and Michael Kolodziej, MD, dig into the other main stakeholders in health care costs: pharmaceutical manufacturers and providers. They discuss how these...
In part two of this two-part...
05/20/2024
Cancer Care Business Exchange
BDHC thumbnail
Breaking Down Health Care
The Bear: Why Does Health Care Cost So Much? (Part 1)
05/06/2024

Featuring Michael Kolodziej, MD, and John Hennessy, MBA

Featuring Michael Kolodziej, MD, and ...
In part one of this two-part Breaking Down Health Care conversation, John Hennessy, MBA, and Michael Kolodziej, MD, dig into two of the main stakeholders in health care costs: hospitals and health insurance companies. They discuss how these...
In part one of this two-part Breaking Down Health Care conversation, John Hennessy, MBA, and Michael Kolodziej, MD, dig into two of the main stakeholders in health care costs: hospitals and health insurance companies. They discuss how these...
In part one of this two-part...
05/06/2024
Cancer Care Business Exchange

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use